Donald Ingber’s keynote at the UC Davis Research Expo, Tuesday, May 16, will address one of his recent innovations, Human Organs-on-Chips, which are being used to replace animal testing for drug development, disease modeling and personalized medicine.

Human Organs-on-Chips, named a Top 10 Emerging Technology of 2016 by the World Economic Forum, are an example of Ingber’s role in breaking down boundaries between science, art and design. Indeed, the London Design Museum recognized Human Organs-on-Chips as Design of the Year in 2015 and New York City’s Museum of Modern Art acquired samples for its permanent design collection, also in 2015.

Ingber is the founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University. He also holds appointments at Harvard Medical School and Boston Children’s Hospital, both in vascular biology, and Harvard’s John A. Paulson School of Engineering and Applied Sciences.

He leads interdisciplinary teams to develop bioinspired technologies to advance health care, making progress in mechanobiology, cell structure, tumor angiogenesis, tissue engineering, systems biology, nanobiotechnology and translational medicine.